跳转至内容
Merck
CN

Serum protein binding of desmethyl-methsuximide.

Clinical neuropharmacology (1999-08-12)
N Wad, B Bourgeois, G Krämer
摘要

Serum protein binding of desmethyl-methsuximide (DM-MSM) in serum from 23 patients on polytherapy were determined using ultrafiltration and high-performance liquid chromatography. Desmethyl-methsuximide, The active metabolite of methsuximide (MSM), was found to have a moderate protein binding ranging between 45% and 60%.